These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 13612965)

  • 1. [Psychic changes in oligophrenic mongoloids observed after prolonged treatment with anterior pituitary extracts].
    SARTORI G
    Minerva Med; 1958 Oct; 49(81):3826-31. PubMed ID: 13612965
    [No Abstract]   [Full Text] [Related]  

  • 2. Two years of pituitary treatment in mongoloids: a clinical study.
    BLUMBERG E
    J Maine Med Assoc; 1959 Apr; 50(4):120-5. PubMed ID: 13641895
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary report on treatment of mongoloids.
    CARTER CH; MALEY MC
    J Fla Med Assoc; 1958 Jan; 44(7):709-13. PubMed ID: 13491786
    [No Abstract]   [Full Text] [Related]  

  • 4. Complementary and alternative therapies for Down syndrome.
    Roizen NJ
    Ment Retard Dev Disabil Res Rev; 2005; 11(2):149-55. PubMed ID: 15977315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possibilities of treatment of mongolism].
    Mommsen H
    Landarzt; 1964 Sep; 40(27):1147-8. PubMed ID: 4220545
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of mongolism with dehydroepiandrosterone].
    DE MORAGAS J
    Rev Esp Pediatr; 1958; 14(82):545-52. PubMed ID: 13591731
    [No Abstract]   [Full Text] [Related]  

  • 7. [Various results with Haubold's after maturation therapy in mongolism].
    JANSON P
    Hippokrates; 1957 May; 28(10):310-2. PubMed ID: 13448604
    [No Abstract]   [Full Text] [Related]  

  • 8. [A 12-week physical activity program increases glucose-6-phosphate-dehydrogenase activity in Down syndrome adolescents].
    Ordóñez FJ; Rosety-Rodríguez M; Rosety M
    Medicina (B Aires); 2005; 65(6):518-20. PubMed ID: 16433479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Good care and treatment of medical problems connected to Down syndrome].
    Suomen Kehitysvammalääkärit-Finlands läkare för utvecklingsstörda ry:n asettama työryhma
    Duodecim; 2004; 120(21):2592-608. PubMed ID: 15631418
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary care for children and adolescents with Down syndrome.
    Davidson MA
    Pediatr Clin North Am; 2008 Oct; 55(5):1099-111, xi. PubMed ID: 18929054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Premature dementia senilis in mongoloids; a clinical study].
    JELGERSMA HC
    Folia Psychiatr Neurol Neurochir Neerl; 1958 Jun; 61(3):367-74. PubMed ID: 13586439
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on serum protein fractions from mongoloids.
    CARVER MJ; WELTON LD
    Dis Nerv Syst; 1961 Feb; 22():84-6. PubMed ID: 13691210
    [No Abstract]   [Full Text] [Related]  

  • 13. Part II: Clinical Practice Guidelines for adolescents and young adults with Down Syndrome: 12 to 21 Years.
    Van Cleve SN; Cannon S; Cohen WI
    J Pediatr Health Care; 2006; 20(3):198-205. PubMed ID: 16675381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Update on current care guidelines. Proper care of medical problems connected to Down Syndrome].
    Kaski M; Autti-Rämö I; Heiskanen K; Huovinen K; Hyvärinen L; Koivikko M; Mäki OA; Noponen AL; Patja K; Pirttilä T; Raitasuo S; Rytsölä E; Verkasalo M; Wilska M
    Duodecim; 2005; 121(19):2118-9. PubMed ID: 16300301
    [No Abstract]   [Full Text] [Related]  

  • 15. Having a perfect child.
    Boehm FH
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):444-5. PubMed ID: 17267848
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing therapy for myeloid disorders of Down syndrome.
    Webb DK
    Br J Haematol; 2005 Oct; 131(1):3-7. PubMed ID: 16173956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Data on glutamic acid therapy of oligophrenia in childhood with special reference to Down's disease].
    GOLLESZ V
    Gyermekgyogyaszat; 1960 Nov; 11():340-4. PubMed ID: 13706714
    [No Abstract]   [Full Text] [Related]  

  • 18. Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments.
    Dierssen M; Ortiz-Abalia J; Arqué G; de Lagrán MM; Fillat C
    Behav Genet; 2006 May; 36(3):454-68. PubMed ID: 16520905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and care of the newborn with Down syndrome.
    Ranweiler R
    Adv Neonatal Care; 2009 Feb; 9(1):17-24; Quiz 25-6. PubMed ID: 19212160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between glutathione peroxidase activity and anthropometrical parameters in adolescents with Down syndrome.
    Ordonez FJ; Rosety-Rodriguez M
    Res Dev Disabil; 2007; 28(1):105-8. PubMed ID: 16563697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.